These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 6184590

  • 1. Reduced lumbar CSF somatostatin levels in Alzheimer's disease.
    Wood PL, Etienne P, Lal S, Gauthier S, Cajal S, Nair NP.
    Life Sci; 1982 Nov 08; 31(19):2073-9. PubMed ID: 6184590
    [No Abstract] [Full Text] [Related]

  • 2. Monoamine metabolite concentrations in lumbar cerebrospinal fluid of patients with histologically verified Alzheimer's dementia.
    Palmer AM, Sims NR, Bowen DM, Neary D, Palo J, Wikstrom J, Davison AN.
    J Neurol Neurosurg Psychiatry; 1984 May 08; 47(5):481-4. PubMed ID: 6204017
    [Abstract] [Full Text] [Related]

  • 3. Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations.
    Losonczy MF, Mohs RC, Davis KL.
    Psychiatry Res; 1984 May 08; 12(1):79-87. PubMed ID: 6205414
    [Abstract] [Full Text] [Related]

  • 4. [CSF somatostatin and amine metabolites in spinocerebellar degenerations].
    Shimoda K, Hikasa C, Nishikawa S, Takahashi K.
    Rinsho Shinkeigaku; 1987 Aug 08; 27(8):996-1001. PubMed ID: 2446812
    [No Abstract] [Full Text] [Related]

  • 5. Concentration gradients for HVA, 5-HIAA, ascorbic acid, and uric acid in cerebrospinal fluid.
    Degrell I, Nagy E.
    Biol Psychiatry; 1990 Apr 15; 27(8):891-6. PubMed ID: 1691925
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features.
    Kaye JA, May C, Daly E, Atack JR, Sweeney DJ, Luxenberg JS, Kay AD, Kaufman S, Milstien S, Friedland RP.
    Neurology; 1988 Apr 15; 38(4):554-7. PubMed ID: 2451190
    [Abstract] [Full Text] [Related]

  • 11. Neurochemical pathology in Korsakoff's psychosis: implications for other cognitive disorders.
    McEntee WJ, Mair RG, Langlais PJ.
    Neurology; 1984 May 15; 34(5):648-52. PubMed ID: 6200802
    [Abstract] [Full Text] [Related]

  • 12. Central amine metabolism in Alzheimer's disease: in vivo relationship to cognitive deficit.
    Mann JJ, Stanley M, Neophytides A, de Leon MJ, Ferris SH, Gershon S.
    Neurobiol Aging; 1981 May 15; 2(1):57-60. PubMed ID: 7266742
    [Abstract] [Full Text] [Related]

  • 13. Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity.
    McEntee WJ, Mair RG.
    Science; 1978 Nov 24; 202(4370):905-7. PubMed ID: 715450
    [Abstract] [Full Text] [Related]

  • 14. Central nervous system catecholamine metabolism in Korsakoff's psychosis.
    Martin PR, Weingartner H, Gordon EK, Burns RS, Linnoila M, Kopin IJ, Ebert MH.
    Ann Neurol; 1984 Feb 24; 15(2):184-7. PubMed ID: 6200058
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dopamine (DA) and serotonin metabolic levels in the cerebrospinal fluid (CSF) in Alzheimer's presenile dementia under basic conditions and after stimulation with cerebral cortex phospholipids (BC-PL).
    Argentiero V, Tavolato B.
    J Neurol; 1980 Feb 24; 224(1):53-8. PubMed ID: 6157799
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. CSF creatinine in schizophrenia.
    Swahn CG, Sedvall G.
    Biol Psychiatry; 1988 Mar 15; 23(6):586-94. PubMed ID: 2451543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.